» Articles » PMID: 18685029

Electrophysiology and Pharmacology of Striatal Neuronal Dysfunction Induced by Mitochondrial Complex I Inhibition

Abstract

Reduced activity of the mitochondrial respiratory chain and in particular of complex I is implicated not only in the etiology of Parkinson's disease but also in other forms of parkinsonism in which striatal neurodegeneration occurs, such as progressive supranuclear palsy. The pesticide rotenone inhibits mitochondrial complex I and reproduces features of these basal ganglia neurological disorders in animal models. We have characterized the electrophysiological effects of rotenone in the striatum as well as potential neuroprotective strategies to counteract the detrimental effects of this neurotoxin. We found that rotenone causes a dose-dependent and irreversible loss of the corticostriatal field potential amplitude, which was related to the development of a membrane depolarization/inward current in striatal spiny neurons, coupled to an increased release of both excitatory amino acids and dopamine (DA). In particular, we have investigated whether glutamate, DA, and GABA systems might represent possible targets for neuroprotection against rotenone-induced striatal neuronal dysfunction. Interestingly, whereas modulation of glutamatergic transmission was not neuroprotective, blockade of D(2)-like but not D(1)-like DA receptors significantly reduced the rotenone-induced effects via a GABA-mediated mechanism. In addition, because antiepileptic drugs (AEDs) modulate multiple transmitter systems, we have analyzed the possible neuroprotective effects of some AEDs against rotenone. We found that carbamazepine, unlike other tested AEDs, exerts a potent neuroprotective action against rotenone-induced striatal neuronal dysfunction. This neuroprotection was observed at therapeutically relevant concentrations requiring endogenous GABA. Differential targeting of GABAergic transmission may represent a possible therapeutic strategy against basal ganglia neurodegenerative disorders involving mitochondrial complex I dysfunction.

Citing Articles

Anethole attenuates motor dysfunctions, striatal neuronal activity deficiency and blood brain barrier permeability by decreasing striatal α-synuclein and oxidative stress in rotenone-induced Parkinson's disease of male rats.

Vastegani S, Khoshnam S, Ghafouri S, Bakhtiari N, Farbood Y, Sarkaki A PLoS One. 2023; 18(11):e0294612.

PMID: 37972114 PMC: 10653401. DOI: 10.1371/journal.pone.0294612.


Traditional and Innovative Anti-seizure Medications Targeting Key Physiopathological Mechanisms: Focus on Neurodevelopment and Neurodegeneration.

Sciaccaluga M, Ruffolo G, Palma E, Costa C Curr Neuropharmacol. 2023; 21(8):1736-1754.

PMID: 37143270 PMC: 10514539. DOI: 10.2174/1570159X21666230504160948.


Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson's disease rat model.

Magdy A, Farrag E, Hamed S, Abdallah Z, El Nashar E, Alghamdi M Front Cell Neurosci. 2022; 16:967813.

PMID: 36187296 PMC: 9522903. DOI: 10.3389/fncel.2022.967813.


Embryonic exposure to benzo[a]pyrene causes age-dependent behavioral alterations and long-term metabolic dysfunction in zebrafish.

Hawkey A, Piatos P, Holloway Z, Boyda J, Koburov R, Fleming E Neurotoxicol Teratol. 2022; 93:107121.

PMID: 36089172 PMC: 9679953. DOI: 10.1016/j.ntt.2022.107121.


Intranasal Administration of Rotenone Reduces GABAergic Inhibition in the Mouse Insular Cortex Leading to Impairment of LTD and Conditioned Taste Aversion Memory.

Toyoda H, Katagiri A, Kato T, Sato H Int J Mol Sci. 2021; 22(1).

PMID: 33383859 PMC: 7795793. DOI: 10.3390/ijms22010259.


References
1.
Tozzi A, Costa C, Di Filippo M, Tantucci M, Siliquini S, Belcastro V . Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. Exp Neurol. 2007; 207(2):218-26. DOI: 10.1016/j.expneurol.2007.06.008. View

2.
Dawson T, Dawson V . Molecular pathways of neurodegeneration in Parkinson's disease. Science. 2003; 302(5646):819-22. DOI: 10.1126/science.1087753. View

3.
Bonsi P, Calabresi P, De Persis C, Papa M, Centonze D, Bernardi G . Early ionic and membrane potential changes caused by the pesticide rotenone in striatal cholinergic interneurons. Exp Neurol. 2003; 185(1):169-81. DOI: 10.1016/j.expneurol.2003.09.016. View

4.
Yoshida S, Okada M, Zhu G, Kaneko S . Carbamazepine prevents breakdown of neurotransmitter release induced by hyperactivation of ryanodine receptor. Neuropharmacology. 2007; 52(7):1538-46. DOI: 10.1016/j.neuropharm.2007.02.009. View

5.
Bracci E, Centonze D, Bernardi G, Calabresi P . Dopamine excites fast-spiking interneurons in the striatum. J Neurophysiol. 2002; 87(4):2190-4. DOI: 10.1152/jn.00754.2001. View